814 related articles for article (PubMed ID: 30598371)
21. A signature of 33 immune-related gene pairs predicts clinical outcome in hepatocellular carcinoma.
Sun XY; Yu SZ; Zhang HP; Li J; Guo WZ; Zhang SJ
Cancer Med; 2020 Apr; 9(8):2868-2878. PubMed ID: 32068352
[TBL] [Abstract][Full Text] [Related]
22. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
[TBL] [Abstract][Full Text] [Related]
23. Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma.
Liao H; Liao M; Xu L; Yan X; Ren B; Zhu Z; Yuan K; Zeng Y
EBioMedicine; 2019 Mar; 41():310-319. PubMed ID: 30665854
[TBL] [Abstract][Full Text] [Related]
24. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
25. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
[TBL] [Abstract][Full Text] [Related]
26. Deep learning-based pathway-centric approach to characterize recurrent hepatocellular carcinoma after liver transplantation.
To J; Ghosh S; Zhao X; Pasini E; Fischer S; Sapisochin G; Ghanekar A; Jaeckel E; Bhat M
Hum Genomics; 2024 Jun; 18(1):58. PubMed ID: 38840185
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas.
Imamura T; Okamura Y; Ohshima K; Uesaka K; Sugiura T; Yamamoto Y; Ashida R; Ohgi K; Nagashima T; Yamaguchi K
J Hepatobiliary Pancreat Sci; 2023 Mar; 30(3):269-282. PubMed ID: 35918906
[TBL] [Abstract][Full Text] [Related]
28. HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
He H; Chen D; Cui S; Wu G; Piao H; Wang X; Ye P; Jin S
BMC Med Genomics; 2020 Aug; 13(1):118. PubMed ID: 32831081
[TBL] [Abstract][Full Text] [Related]
29. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
[TBL] [Abstract][Full Text] [Related]
30. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
31. Role of CCR1/5/7 in hepatocellular carcinoma: a study on prognostic evaluation, molecular subtyping, and association with immune infiltration.
Huang H; Lan C; Wei Y; Nong J; Liao X; Ye X; Deng G; Peng T; Zhou X
Aging (Albany NY); 2024 Mar; 16(7):6229-6261. PubMed ID: 38552222
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide identification of differential methylation between primary and recurrent hepatocellular carcinomas.
Cui C; Lu Z; Yang L; Gao Y; Liu W; Gu L; Yang C; Wilson J; Zhang Z; Xing B; Deng D; Sun ZS
Mol Carcinog; 2016 Jul; 55(7):1163-74. PubMed ID: 26138747
[TBL] [Abstract][Full Text] [Related]
33. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
Ao L; Song X; Li X; Tong M; Guo Y; Li J; Li H; Cai H; Li M; Guan Q; Yan H; Guo Z
Oncotarget; 2016 Apr; 7(17):24097-110. PubMed ID: 27006471
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic and Immune-Cell Infiltration Changes in the Tumor Microenvironment in Hepatocellular Carcinoma.
Wu ZH; Yang DL; Wang L; Liu J
Front Immunol; 2021; 12():793343. PubMed ID: 34925377
[TBL] [Abstract][Full Text] [Related]
35. A novel hypoxia gene signature indicates prognosis and immune microenvironments characters in patients with hepatocellular carcinoma.
Zhang Q; Qiao L; Liao J; Liu Q; Liu P; Liu L
J Cell Mol Med; 2021 Apr; 25(8):3772-3784. PubMed ID: 33616276
[TBL] [Abstract][Full Text] [Related]
36. Identification of survival-related predictors in hepatocellular carcinoma through integrated genomic, transcriptomic, and proteomic analyses.
Dong F; Yang Q; Wu Z; Hu X; Shi D; Feng M; Li J; Zhu L; Jiang S; Bao Z
Biomed Pharmacother; 2019 Jun; 114():108856. PubMed ID: 30981109
[TBL] [Abstract][Full Text] [Related]
37. Integrative analysis reveals novel driver genes and molecular subclasses of hepatocellular carcinoma.
Yang L; Zhang Z; Sun Y; Pang S; Yao Q; Lin P; Cheng J; Li J; Ding G; Hui L; Li Y; Li H
Aging (Albany NY); 2020 Nov; 12(23):23849-23871. PubMed ID: 33221766
[TBL] [Abstract][Full Text] [Related]
38. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
Hu B; Yang XB; Sang XT
Int Immunopharmacol; 2021 Jan; 90():107164. PubMed ID: 33172741
[TBL] [Abstract][Full Text] [Related]
39. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
[TBL] [Abstract][Full Text] [Related]
40. Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma.
Bassaganyas L; Pinyol R; Esteban-Fabró R; Torrens L; Torrecilla S; Willoughby CE; Franch-Expósito S; Vila-Casadesús M; Salaverria I; Montal R; Mazzaferro V; Camps J; Sia D; Llovet JM
Clin Cancer Res; 2020 Dec; 26(23):6350-6361. PubMed ID: 32873569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
